Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic therapies for neuroblastoma: immunogenicity awakens

25 Feb 2023

Abstract excerpt

The development of immunotherapies for neuroblastoma remains challenging owing to the low immunogenicity of neuroblastoma cells, as reflected by the low expression of one of the main triggers of immune recognition, the major histocompatibility complex class I (MHC-I). Cornel et al. showed that epigenetic modulation of neuroblastoma cells with a histone deacetylase inhibitor can boost the expression of major...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36840349
DOI: 10.1002/1878-0261.13404

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic therapies for neuroblastoma: immunogenicity awakensPMID 36840349Read ↗

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk NeuroblastomaSemantic proximity Read ↗

Immunotherapy of Neuroblastoma: Facts and HopesSemantic proximity Read ↗

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesSemantic proximity Read ↗

Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective TreatmentSemantic proximity Read ↗

State of the Art in Immunotherapy of NeuroblastomaSemantic proximity Read ↗

The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapiesSemantic proximity Read ↗

Exploring and Targeting the Tumor Immune Microenvironment of NeuroblastomaSemantic proximity Read ↗

Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in NeuroblastomaSemantic proximity Read ↗

Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memorySemantic proximity Read ↗

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes.Semantic proximity Read ↗

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Semantic proximity Read ↗

Epigenetic modulation of immunotherapy and implications in head and neck cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.